Search

for
Search:

Did you mean QR678 Neo?

GlossaryQR678 Neo

proprietary hair regrowth treatment using specific growth factors

QR678 Neo is a proprietary hair regrowth treatment that involves a blend of specific growth factors designed to stimulate hair follicles and promote hair growth. It is often used to treat conditions like androgenetic alopecia and other forms of hair loss, offering a non-surgical alternative to traditional hair restoration methods.

Related Terms

Sort by

Research

30 / 306 results

Comparison of QR 678 and QR 678 Neo as Monotherapy and Combination Therapy with 5% Minoxidil Solution and Oral Finasteride in the Treatment of Male Androgenetic Alopecia—Which Is Better?

research “Comparison of QR 678 ® & QR678 ® Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia—Which is better?”

3 citations , April 2021 in “Journal of Cosmetic Dermatology”

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

QR 678 and QR678 Neo vs PRP—A Randomized, Comparative, Prospective Study

research QR 678 & QR678 Neo Vs PRP—A randomised, comparative, prospective study

14 citations , April 2020 in “Journal of Cosmetic Dermatology”

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

Evaluation of Efficacy of QR 678 and QR678 Neo Hair Growth Factor Formulation for the Treatment of Female Pattern Alopecia in Patients with PCOS—A Prospective Study

research Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study

4 citations , August 2020 in “Journal of Cosmetic Dermatology”

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Efficacy of QR678 Neo Hair Growth Factor Formulation for the Treatment of Hair Loss in COVID-19-Induced Persistent Telogen Effluvium: A Prospective, Clinical, Single-Blind Study

research Efficacy of QR678 Neo^® hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study

5 citations , December 2021 in “Journal of Cosmetic Dermatology”

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Effectiveness of QR678 and QR678 Neo with Intralesional Corticosteroid vs. Intralesional Corticosteroid Alone in the Treatment of Alopecia Areata – A Randomized, Comparative, Prospective Study

research Effectiveness of QR678 and QR678 Neo ^® with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata –A randomized, comparative, prospective study

4 citations , November 2021 in “Journal of Cosmetic Dermatology”

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Evaluation of Efficacy of Intradermal Injection Therapy vs Derma Roller Application for Administration of QR678 Neo Hair Regrowth Formulation for the Treatment of Androgenetic Alopecia—A Prospective Study

research Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo ^® hair regrowth formulation for the treatment of Androgenetic Alopecia—A prospective study

4 citations , April 2021 in “Journal of Cosmetic Dermatology”

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

Evaluation of the Safety and Effectiveness of Intradermal Administration of QR678 Neo Hair Growth Factor Formulation: A Phase-IV, Open-Label, Single-Arm Multi-Ethnicity Clinical Trial

research Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo^® hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial

2 citations , January 2022 in “Journal of Cosmetic Dermatology”

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

research Comparison between QR678 neo and platelet rich plasma for hair growth -A retrospective study

December 2024 in “Journal of Dental Panacea”

QR678 Neo is more effective than PRP for hair growth and quality.

research A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®—A prospective pilot study

August 2023 in “Journal of Cosmetic Dermatology”

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

research Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia

September 2022 in “Journal of Cosmetic Dermatology”

Evaluation of the Efficacy of a Biomimetic Peptide Solution for Rejuvenation of Donor Scalp and as Storage Media for Hair Follicle Grafts During FUE Hair Transplantation

research Evaluation of the efficacy of a biomimetic peptide solution for rejuvenation of donor scalp and as storage media for hair follicle grafts during FUE hair transplantation

April 2025 in “Journal of Cosmetic and Laser Therapy”

QR678 Neo® improves hair transplant success and hair regrowth.

research Evolution and Trends of Facial Plastic Surgery and Facial Aesthetic Procedures in India: From Awakening to Revival

1 citations , January 2023 in “Aesthetic surgery journal”

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

research Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management

157 citations , May 2021 in “Endocrine Reviews”

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

research Enhanced Differentiation Potential of Pigmented Human Epidermal Equivalents

May 2025

PmtHEE is a better model for studying pigmented skin because it includes melanocytes and shows improved cell differentiation.

research Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions

December 2025 in “ADMET & DMPK”

Personalized treatments for hair loss focus on specific genetic and biological pathways.

research Platelet‐rich plasma for androgenetic alopecia: Efficacy differences between men and women

10 citations , August 2020 in “Dermatologic Therapy”

PRP improves hair thickness for both genders, but only increases hair density in men.

research Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia

March 2026 in “Frontiers in Pharmacology”

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Higher PDCD4 Expression Is Associated With Obesity, Insulin Resistance, Lipid Metabolism Disorders, And Granulosa Cell Apoptosis In Polycystic Ovary Syndrome

research Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome

34 citations , February 2016 in “Fertility and Sterility”

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

research Platelet-rich Plasma and Cell Therapy

11 citations , May 2021 in “Dermatologic clinics”

PRP and cell therapies may help with hair loss, but more research is needed.

research Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity

8 citations , May 2022 in “Journal of medicine and life”

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

research Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis

7 citations , February 2022 in “Journal of Personalized Medicine”

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

research Platelet-Rich Plasma in Plastic Surgery: A Systematic Review

4 citations , January 2022 in “Transfusion Medicine and Hemotherapy”

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

research Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia

January 2026 in “Pharmaceutical Medicine”

Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and Exosomes

research Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and Exosomes

December 2025 in “Medical Sciences”

Regenerative therapies show promise for hair regrowth, but more research and standardization are needed.

Autologous Platelet Concentrates in Aesthetic Medicine

research Autolougous platelet concentrates in esthetic medicine

July 2024 in “Periodontology 2000”

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

research Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.

16 citations , November 2011 in “PubMed”

The treatment improved hair growth in people with male pattern baldness.

research Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies

3 citations , August 2022 in “International Journal of Molecular Sciences”

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.